A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

Show other versions (1)

Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present study aimed to establish a bioinformatics pipeline capable of defining and validating NAFLD biomarker candidates based on paired hepatic globa...

Full description

Bibliographic Details
Main Authors: Christoffer A. Hagemann, Christian Legart, Mathias B. Møllerhøj, Martin R. Madsen, Henrik H. Hansen, Merete J. Kønig, Frederik Helgstrand, Flemming P. Hjørne, Anders Toxværd, Jill L. Langhoff, Urd L. Kielgast, Lise L. Gluud, Helene Ægidius, Kristoffer T. G. Rigbolt, Tina Vilsbøll, Jacob Jelsing, Filip K. Knop
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581378/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581378/?tool=EBI

Similar Items